Share Price and Basic Stock Data
Last Updated: January 24, 2026, 4:25 pm
| PEG Ratio | 2.12 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Narayana Hrudayalaya Ltd operates in the hospitals and medical services sector, demonstrating a robust business model backed by consistent revenue growth. For the fiscal year ending March 2025, the company reported sales of ₹5,483 Cr, reflecting an upward trajectory from ₹4,525 Cr in March 2023. The trailing twelve months (TTM) sales stood at ₹5,961 Cr, indicating a healthy increase and showcasing its ability to capture market share. This growth is further supported by quarterly revenue figures, with sales reaching ₹1,367 Cr in September 2024 and projected to touch ₹1,644 Cr by September 2025. Such revenue trends are indicative of Narayana Hrudayalaya’s effective operational strategies and expanding patient base, positioning it favorably within the competitive healthcare landscape in India.
Profitability and Efficiency Metrics
The company has exhibited strong profitability metrics, with a reported net profit of ₹791 Cr for the fiscal year ending March 2025, an increase from ₹607 Cr in March 2023. The operating profit margin (OPM) for March 2025 stood at 24%, consistent with the previous year, reflecting efficient cost management and operational effectiveness. The return on equity (ROE) was recorded at 24.2%, which is commendable compared to typical sector benchmarks. Narayana Hrudayalaya also reported a return on capital employed (ROCE) of 21%, indicating effective utilization of capital to generate profits. The interest coverage ratio (ICR) was robust at 9.35x, suggesting that the company is well-positioned to meet its debt obligations, further reinforcing its operational efficiency and financial health.
Balance Sheet Strength and Financial Ratios
Narayana Hrudayalaya’s balance sheet reflects strength with total assets amounting to ₹7,271 Cr as of March 2025, an increase from ₹4,170 Cr in March 2023. The company’s reserves have also shown significant growth, rising to ₹3,855 Cr by September 2025 from ₹1,927 Cr in March 2023. The total borrowings stood at ₹2,340 Cr, indicating a manageable debt level relative to the equity capital of ₹204 Cr. The debt-to-equity ratio was reported at 0.61x, suggesting that the company maintains a conservative leverage position. Additionally, the current ratio of 2.14x indicates strong liquidity, allowing Narayana Hrudayalaya to cover its short-term liabilities comfortably, thus enhancing investor confidence in its financial stability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Narayana Hrudayalaya demonstrates a stable and committed investor base, with promoters holding 63.85% of the equity. The foreign institutional investors (FIIs) stake stood at 10.49%, reflecting a slight increase from previous quarters, while domestic institutional investors (DIIs) controlled 7.76%. The public shareholding has grown to 17.29%, indicating increasing retail investor interest. With the number of shareholders rising from 73,157 in December 2022 to 2,26,480 by September 2025, it showcases a growing confidence in the company’s prospects. This diverse and expanding shareholder base could provide a buffer against market fluctuations and enhance the company’s reputation within the investment community.
Outlook, Risks, and Final Insight
The outlook for Narayana Hrudayalaya appears positive, driven by its strong revenue growth, solid profitability metrics, and healthy balance sheet. However, potential risks include rising operational costs and increasing competition in the healthcare sector, which could pressure profit margins. Additionally, the company’s reliance on debt could pose challenges if interest rates rise. On the other hand, if the company successfully expands its services and maintains its operational efficiency, it can leverage its competitive advantages to capture a larger market share. Ultimately, Narayana Hrudayalaya’s strategic initiatives and adaptability will be crucial in navigating the evolving healthcare landscape and sustaining its growth trajectory.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Dr Lalchandani Labs Ltd | 9.06 Cr. | 20.9 | 28.7/9.80 | 19.3 | 23.4 | 0.00 % | 2.81 % | 3.08 % | 10.0 |
| Asarfi Hospital Ltd | 327 Cr. | 166 | 221/72.9 | 23.3 | 45.2 | 0.00 % | 15.8 % | 14.1 % | 10.0 |
| Narayana Hrudayalaya Ltd | 35,696 Cr. | 1,747 | 2,372/1,259 | 42.0 | 199 | 0.26 % | 20.8 % | 24.2 % | 10.0 |
| Lotus Eye Hospital & Institute Ltd | 254 Cr. | 122 | 141/55.0 | 379 | 29.2 | 0.00 % | 2.99 % | 1.22 % | 10.0 |
| Industry Average | 12,092.33 Cr | 513.98 | 115.90 | 74.20 | 0.07% | 10.60% | 10.65% | 10.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,142 | 1,128 | 1,222 | 1,233 | 1,305 | 1,204 | 1,246 | 1,306 | 1,367 | 1,335 | 1,475 | 1,507 | 1,644 |
| Expenses | 898 | 874 | 946 | 963 | 997 | 925 | 955 | 1,004 | 1,058 | 1,027 | 1,118 | 1,171 | 1,243 |
| Operating Profit | 244 | 254 | 276 | 271 | 308 | 279 | 291 | 302 | 309 | 307 | 358 | 337 | 401 |
| OPM % | 21% | 23% | 23% | 22% | 24% | 23% | 23% | 23% | 23% | 23% | 24% | 22% | 24% |
| Other Income | 31 | 12 | 15 | 15 | 18 | 18 | 26 | 24 | 23 | 18 | 20 | 24 | 24 |
| Interest | 15 | 19 | 21 | 21 | 23 | 25 | 28 | 34 | 35 | 37 | 41 | 45 | 42 |
| Depreciation | 49 | 57 | 56 | 59 | 55 | 63 | 65 | 61 | 65 | 70 | 82 | 84 | 87 |
| Profit before tax | 211 | 190 | 214 | 206 | 248 | 209 | 225 | 231 | 232 | 219 | 254 | 232 | 296 |
| Tax % | 20% | 19% | 19% | 11% | 9% | 10% | 15% | 13% | 14% | 12% | 22% | 15% | 13% |
| Net Profit | 169 | 154 | 173 | 184 | 227 | 188 | 191 | 202 | 199 | 193 | 197 | 197 | 258 |
| EPS in Rs | 8.26 | 7.52 | 8.47 | 9.00 | 11.09 | 9.20 | 9.33 | 9.85 | 9.72 | 9.44 | 9.65 | 9.62 | 12.64 |
Last Updated: January 11, 2026, 8:33 am
Below is a detailed analysis of the quarterly data for Narayana Hrudayalaya Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 1,644.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,507.00 Cr. (Jun 2025) to 1,644.00 Cr., marking an increase of 137.00 Cr..
- For Expenses, as of Sep 2025, the value is 1,243.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,171.00 Cr. (Jun 2025) to 1,243.00 Cr., marking an increase of 72.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 401.00 Cr.. The value appears strong and on an upward trend. It has increased from 337.00 Cr. (Jun 2025) to 401.00 Cr., marking an increase of 64.00 Cr..
- For OPM %, as of Sep 2025, the value is 24.00%. The value appears strong and on an upward trend. It has increased from 22.00% (Jun 2025) to 24.00%, marking an increase of 2.00%.
- For Other Income, as of Sep 2025, the value is 24.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 24.00 Cr..
- For Interest, as of Sep 2025, the value is 42.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 45.00 Cr. (Jun 2025) to 42.00 Cr., marking a decrease of 3.00 Cr..
- For Depreciation, as of Sep 2025, the value is 87.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 84.00 Cr. (Jun 2025) to 87.00 Cr., marking an increase of 3.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 296.00 Cr.. The value appears strong and on an upward trend. It has increased from 232.00 Cr. (Jun 2025) to 296.00 Cr., marking an increase of 64.00 Cr..
- For Tax %, as of Sep 2025, the value is 13.00%. The value appears to be improving (decreasing) as expected. It has decreased from 15.00% (Jun 2025) to 13.00%, marking a decrease of 2.00%.
- For Net Profit, as of Sep 2025, the value is 258.00 Cr.. The value appears strong and on an upward trend. It has increased from 197.00 Cr. (Jun 2025) to 258.00 Cr., marking an increase of 61.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 12.64. The value appears strong and on an upward trend. It has increased from 9.62 (Jun 2025) to 12.64, marking an increase of 3.02.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:55 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,095 | 1,364 | 1,614 | 1,878 | 2,281 | 2,861 | 3,128 | 2,583 | 3,701 | 4,525 | 4,890 | 5,483 | 5,961 |
| Expenses | 989 | 1,236 | 1,434 | 1,642 | 2,064 | 2,566 | 2,694 | 2,394 | 3,038 | 3,538 | 3,722 | 4,185 | 4,558 |
| Operating Profit | 106 | 128 | 180 | 236 | 217 | 295 | 434 | 189 | 664 | 987 | 1,168 | 1,298 | 1,403 |
| OPM % | 10% | 9% | 11% | 13% | 10% | 10% | 14% | 7% | 18% | 22% | 24% | 24% | 24% |
| Other Income | 39 | 6 | -19 | 7 | 18 | 16 | 7 | 21 | 26 | 59 | 73 | 80 | 86 |
| Interest | 31 | 45 | 33 | 28 | 55 | 81 | 94 | 82 | 76 | 84 | 112 | 163 | 165 |
| Depreciation | 57 | 68 | 76 | 80 | 100 | 137 | 186 | 184 | 183 | 210 | 241 | 278 | 324 |
| Profit before tax | 57 | 21 | 51 | 135 | 80 | 93 | 161 | -56 | 430 | 752 | 888 | 936 | 1,000 |
| Tax % | 38% | 71% | 59% | 39% | 36% | 37% | 26% | -75% | 20% | 19% | 11% | 16% | |
| Net Profit | 29 | -19 | 21 | 83 | 51 | 59 | 119 | -14 | 342 | 607 | 790 | 791 | 846 |
| EPS in Rs | 974.49 | -0.84 | 1.04 | 4.06 | 2.51 | 2.90 | 5.82 | -0.70 | 16.73 | 29.67 | 38.62 | 38.66 | 41.35 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 35% | 17% | 0% | 6% | 8% | 10% | 12% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -165.52% | 210.53% | 295.24% | -38.55% | 15.69% | 101.69% | -111.76% | 2542.86% | 77.49% | 30.15% | 0.13% |
| Change in YoY Net Profit Growth (%) | 0.00% | 376.04% | 84.71% | -333.79% | 54.24% | 86.01% | -213.46% | 2654.62% | -2465.37% | -47.34% | -30.02% |
Narayana Hrudayalaya Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 12% |
| 3 Years: | 14% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 48% |
| 5 Years: | 43% |
| 3 Years: | 31% |
| TTM: | -2% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 42% |
| 3 Years: | 37% |
| 1 Year: | 42% |
| Return on Equity | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 25% |
| 3 Years: | 29% |
| Last Year: | 24% |
Last Updated: September 5, 2025, 11:30 am
Balance Sheet
Last Updated: December 10, 2025, 3:08 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.33 | 200 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 |
| Reserves | 580 | 568 | 672 | 759 | 831 | 877 | 932 | 916 | 1,284 | 1,927 | 2,679 | 3,422 | 3,855 |
| Borrowings | 333 | 362 | 258 | 217 | 802 | 813 | 952 | 826 | 723 | 884 | 1,627 | 2,428 | 2,340 |
| Other Liabilities | 242 | 241 | 424 | 468 | 692 | 746 | 813 | 833 | 931 | 1,155 | 1,123 | 1,216 | 1,342 |
| Total Liabilities | 1,156 | 1,371 | 1,557 | 1,648 | 2,529 | 2,640 | 2,901 | 2,779 | 3,143 | 4,170 | 5,633 | 7,271 | 7,742 |
| Fixed Assets | 738 | 913 | 1,054 | 1,082 | 1,848 | 1,838 | 2,092 | 1,961 | 1,980 | 2,336 | 2,651 | 4,266 | 4,399 |
| CWIP | 20 | 20 | 14 | 53 | 35 | 56 | 12 | 20 | 67 | 259 | 514 | 86 | 135 |
| Investments | 51 | 52 | 87 | 96 | 9 | 17 | 86 | 120 | 132 | 252 | 844 | 1,084 | 1,435 |
| Other Assets | 346 | 385 | 402 | 417 | 637 | 729 | 711 | 678 | 964 | 1,323 | 1,624 | 1,835 | 1,773 |
| Total Assets | 1,156 | 1,371 | 1,557 | 1,648 | 2,529 | 2,640 | 2,901 | 2,779 | 3,143 | 4,170 | 5,633 | 7,271 | 7,742 |
Below is a detailed analysis of the balance sheet data for Narayana Hrudayalaya Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 204.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 204.00 Cr..
- For Reserves, as of Sep 2025, the value is 3,855.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,422.00 Cr. (Mar 2025) to 3,855.00 Cr., marking an increase of 433.00 Cr..
- For Borrowings, as of Sep 2025, the value is 2,340.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 2,428.00 Cr. (Mar 2025) to 2,340.00 Cr., marking a decrease of 88.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,342.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,216.00 Cr. (Mar 2025) to 1,342.00 Cr., marking an increase of 126.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 7,742.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 7,271.00 Cr. (Mar 2025) to 7,742.00 Cr., marking an increase of 471.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 4,399.00 Cr.. The value appears strong and on an upward trend. It has increased from 4,266.00 Cr. (Mar 2025) to 4,399.00 Cr., marking an increase of 133.00 Cr..
- For CWIP, as of Sep 2025, the value is 135.00 Cr.. The value appears strong and on an upward trend. It has increased from 86.00 Cr. (Mar 2025) to 135.00 Cr., marking an increase of 49.00 Cr..
- For Investments, as of Sep 2025, the value is 1,435.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,084.00 Cr. (Mar 2025) to 1,435.00 Cr., marking an increase of 351.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,773.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,835.00 Cr. (Mar 2025) to 1,773.00 Cr., marking a decrease of 62.00 Cr..
- For Total Assets, as of Sep 2025, the value is 7,742.00 Cr.. The value appears strong and on an upward trend. It has increased from 7,271.00 Cr. (Mar 2025) to 7,742.00 Cr., marking an increase of 471.00 Cr..
Notably, the Reserves (3,855.00 Cr.) exceed the Borrowings (2,340.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -227.00 | -234.00 | -78.00 | 19.00 | -585.00 | -518.00 | -518.00 | -637.00 | -59.00 | 103.00 | 0.00 | -1.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 45 | 38 | 34 | 30 | 45 | 34 | 31 | 39 | 43 | 35 | 31 | 37 |
| Inventory Days | 64 | 56 | 48 | 45 | 56 | 48 | 35 | 32 | 30 | 31 | 44 | 40 |
| Days Payable | 198 | 146 | 152 | 173 | 200 | 177 | 177 | 221 | 180 | 224 | 214 | 185 |
| Cash Conversion Cycle | -90 | -51 | -70 | -98 | -100 | -95 | -111 | -150 | -108 | -158 | -138 | -108 |
| Working Capital Days | 2 | -30 | -12 | -11 | -10 | -10 | -22 | -38 | -16 | -25 | -30 | -17 |
| ROCE % | 8% | 7% | 9% | 14% | 9% | 9% | 14% | 2% | 25% | 32% | 26% | 21% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Parag Parikh Flexi Cap Fund | 1,995,914 | 0.3 | 388.31 | N/A | N/A | N/A |
| Axis Small Cap Fund | 1,663,780 | 1.21 | 323.69 | 6,641,167 | 2025-12-08 02:06:47 | -74.95% |
| Mirae Asset Large & Midcap Fund | 1,618,507 | 0.72 | 314.88 | N/A | N/A | N/A |
| Mirae Asset Midcap Fund | 1,091,916 | 1.16 | 212.43 | 755,540 | 2025-12-15 03:48:53 | 44.52% |
| Nippon India Small Cap Fund | 944,173 | 0.27 | 183.69 | N/A | N/A | N/A |
| Nippon India Pharma Fund | 923,911 | 2.12 | 179.75 | 1,849,571 | 2025-12-08 02:06:47 | -50.05% |
| DSP Small Cap Fund | 721,175 | 0.82 | 140.3 | 1,801,189 | 2025-12-08 02:06:47 | -59.96% |
| Nippon India Multi Cap Fund | 248,289 | 0.1 | 48.3 | 828,028 | 2025-12-15 03:48:53 | -70.01% |
| WhiteOak Capital Mid Cap Fund | 207,666 | 0.93 | 40.4 | N/A | N/A | N/A |
| Axis Multicap Fund | 171,898 | 0.36 | 33.44 | 907,694 | 2025-12-08 02:06:47 | -81.06% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 38.90 | 38.86 | 29.85 | 16.85 | -0.70 |
| Diluted EPS (Rs.) | 38.90 | 38.86 | 29.85 | 16.85 | -0.70 |
| Cash EPS (Rs.) | 52.30 | 50.49 | 39.97 | 26.14 | 8.62 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 177.34 | 141.18 | 104.35 | 72.88 | 54.84 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 177.34 | 141.18 | 104.35 | 72.88 | 54.84 |
| Revenue From Operations / Share (Rs.) | 268.30 | 245.56 | 221.41 | 181.12 | 126.36 |
| PBDIT / Share (Rs.) | 66.96 | 60.07 | 50.46 | 33.67 | 10.29 |
| PBIT / Share (Rs.) | 53.35 | 48.22 | 40.19 | 24.69 | 1.31 |
| PBT / Share (Rs.) | 45.78 | 43.48 | 36.79 | 21.45 | -2.41 |
| Net Profit / Share (Rs.) | 38.69 | 38.64 | 29.69 | 17.16 | -0.36 |
| NP After MI And SOA / Share (Rs.) | 38.66 | 38.62 | 29.66 | 16.73 | -0.69 |
| PBDIT Margin (%) | 24.95 | 24.46 | 22.79 | 18.59 | 8.14 |
| PBIT Margin (%) | 19.88 | 19.63 | 18.14 | 13.63 | 1.03 |
| PBT Margin (%) | 17.06 | 17.70 | 16.61 | 11.84 | -1.90 |
| Net Profit Margin (%) | 14.41 | 15.73 | 13.40 | 9.47 | -0.28 |
| NP After MI And SOA Margin (%) | 14.41 | 15.72 | 13.39 | 9.23 | -0.55 |
| Return on Networth / Equity (%) | 21.80 | 27.36 | 28.44 | 22.96 | -1.27 |
| Return on Capital Employeed (%) | 17.95 | 21.82 | 25.86 | 21.46 | 1.29 |
| Return On Assets (%) | 10.87 | 14.03 | 14.56 | 10.92 | -0.51 |
| Long Term Debt / Equity (X) | 0.54 | 0.41 | 0.29 | 0.29 | 0.44 |
| Total Debt / Equity (X) | 0.61 | 0.50 | 0.35 | 0.36 | 0.46 |
| Asset Turnover Ratio (%) | 0.85 | 1.03 | 1.00 | 0.95 | 0.66 |
| Current Ratio (X) | 2.14 | 1.75 | 1.31 | 1.17 | 0.94 |
| Quick Ratio (X) | 2.04 | 1.65 | 1.24 | 1.09 | 0.87 |
| Inventory Turnover Ratio (X) | 49.80 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 10.28 | 6.43 | 3.34 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 7.60 | 4.92 | 2.48 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 89.72 | 93.57 | 96.66 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 92.40 | 95.08 | 97.52 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 9.35 | 12.67 | 14.85 | 10.38 | 2.77 |
| Interest Coverage Ratio (Post Tax) (X) | 6.45 | 9.15 | 9.74 | 6.29 | 0.90 |
| Enterprise Value (Cr.) | 36133.09 | 27191.98 | 16202.98 | 15629.99 | 8692.93 |
| EV / Net Operating Revenue (X) | 6.59 | 5.42 | 3.58 | 4.22 | 3.37 |
| EV / EBITDA (X) | 26.40 | 22.15 | 15.71 | 22.72 | 41.34 |
| MarketCap / Net Operating Revenue (X) | 6.30 | 5.21 | 3.50 | 4.12 | 3.21 |
| Retention Ratios (%) | 89.71 | 93.56 | 96.65 | 0.00 | 0.00 |
| Price / BV (X) | 9.54 | 9.07 | 7.42 | 10.25 | 7.41 |
| Price / Net Operating Revenue (X) | 6.30 | 5.21 | 3.50 | 4.12 | 3.21 |
| EarningsYield | 0.02 | 0.03 | 0.03 | 0.02 | 0.00 |
After reviewing the key financial ratios for Narayana Hrudayalaya Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 38.90. This value is within the healthy range. It has increased from 38.86 (Mar 24) to 38.90, marking an increase of 0.04.
- For Diluted EPS (Rs.), as of Mar 25, the value is 38.90. This value is within the healthy range. It has increased from 38.86 (Mar 24) to 38.90, marking an increase of 0.04.
- For Cash EPS (Rs.), as of Mar 25, the value is 52.30. This value is within the healthy range. It has increased from 50.49 (Mar 24) to 52.30, marking an increase of 1.81.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 177.34. It has increased from 141.18 (Mar 24) to 177.34, marking an increase of 36.16.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 177.34. It has increased from 141.18 (Mar 24) to 177.34, marking an increase of 36.16.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 268.30. It has increased from 245.56 (Mar 24) to 268.30, marking an increase of 22.74.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 66.96. This value is within the healthy range. It has increased from 60.07 (Mar 24) to 66.96, marking an increase of 6.89.
- For PBIT / Share (Rs.), as of Mar 25, the value is 53.35. This value is within the healthy range. It has increased from 48.22 (Mar 24) to 53.35, marking an increase of 5.13.
- For PBT / Share (Rs.), as of Mar 25, the value is 45.78. This value is within the healthy range. It has increased from 43.48 (Mar 24) to 45.78, marking an increase of 2.30.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 38.69. This value is within the healthy range. It has increased from 38.64 (Mar 24) to 38.69, marking an increase of 0.05.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 38.66. This value is within the healthy range. It has increased from 38.62 (Mar 24) to 38.66, marking an increase of 0.04.
- For PBDIT Margin (%), as of Mar 25, the value is 24.95. This value is within the healthy range. It has increased from 24.46 (Mar 24) to 24.95, marking an increase of 0.49.
- For PBIT Margin (%), as of Mar 25, the value is 19.88. This value is within the healthy range. It has increased from 19.63 (Mar 24) to 19.88, marking an increase of 0.25.
- For PBT Margin (%), as of Mar 25, the value is 17.06. This value is within the healthy range. It has decreased from 17.70 (Mar 24) to 17.06, marking a decrease of 0.64.
- For Net Profit Margin (%), as of Mar 25, the value is 14.41. This value exceeds the healthy maximum of 10. It has decreased from 15.73 (Mar 24) to 14.41, marking a decrease of 1.32.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 14.41. This value is within the healthy range. It has decreased from 15.72 (Mar 24) to 14.41, marking a decrease of 1.31.
- For Return on Networth / Equity (%), as of Mar 25, the value is 21.80. This value is within the healthy range. It has decreased from 27.36 (Mar 24) to 21.80, marking a decrease of 5.56.
- For Return on Capital Employeed (%), as of Mar 25, the value is 17.95. This value is within the healthy range. It has decreased from 21.82 (Mar 24) to 17.95, marking a decrease of 3.87.
- For Return On Assets (%), as of Mar 25, the value is 10.87. This value is within the healthy range. It has decreased from 14.03 (Mar 24) to 10.87, marking a decrease of 3.16.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.54. This value is within the healthy range. It has increased from 0.41 (Mar 24) to 0.54, marking an increase of 0.13.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.61. This value is within the healthy range. It has increased from 0.50 (Mar 24) to 0.61, marking an increase of 0.11.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.85. It has decreased from 1.03 (Mar 24) to 0.85, marking a decrease of 0.18.
- For Current Ratio (X), as of Mar 25, the value is 2.14. This value is within the healthy range. It has increased from 1.75 (Mar 24) to 2.14, marking an increase of 0.39.
- For Quick Ratio (X), as of Mar 25, the value is 2.04. This value exceeds the healthy maximum of 2. It has increased from 1.65 (Mar 24) to 2.04, marking an increase of 0.39.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 49.80. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 49.80, marking an increase of 49.80.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 10.28. This value is below the healthy minimum of 20. It has increased from 6.43 (Mar 24) to 10.28, marking an increase of 3.85.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 7.60. This value is below the healthy minimum of 20. It has increased from 4.92 (Mar 24) to 7.60, marking an increase of 2.68.
- For Earning Retention Ratio (%), as of Mar 25, the value is 89.72. This value exceeds the healthy maximum of 70. It has decreased from 93.57 (Mar 24) to 89.72, marking a decrease of 3.85.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 92.40. This value exceeds the healthy maximum of 70. It has decreased from 95.08 (Mar 24) to 92.40, marking a decrease of 2.68.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 9.35. This value is within the healthy range. It has decreased from 12.67 (Mar 24) to 9.35, marking a decrease of 3.32.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 6.45. This value is within the healthy range. It has decreased from 9.15 (Mar 24) to 6.45, marking a decrease of 2.70.
- For Enterprise Value (Cr.), as of Mar 25, the value is 36,133.09. It has increased from 27,191.98 (Mar 24) to 36,133.09, marking an increase of 8,941.11.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.59. This value exceeds the healthy maximum of 3. It has increased from 5.42 (Mar 24) to 6.59, marking an increase of 1.17.
- For EV / EBITDA (X), as of Mar 25, the value is 26.40. This value exceeds the healthy maximum of 15. It has increased from 22.15 (Mar 24) to 26.40, marking an increase of 4.25.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 6.30. This value exceeds the healthy maximum of 3. It has increased from 5.21 (Mar 24) to 6.30, marking an increase of 1.09.
- For Retention Ratios (%), as of Mar 25, the value is 89.71. This value exceeds the healthy maximum of 70. It has decreased from 93.56 (Mar 24) to 89.71, marking a decrease of 3.85.
- For Price / BV (X), as of Mar 25, the value is 9.54. This value exceeds the healthy maximum of 3. It has increased from 9.07 (Mar 24) to 9.54, marking an increase of 0.47.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 6.30. This value exceeds the healthy maximum of 3. It has increased from 5.21 (Mar 24) to 6.30, marking an increase of 1.09.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.02, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Narayana Hrudayalaya Ltd:
- Net Profit Margin: 14.41%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 17.95% (Industry Average ROCE: 10.6%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 21.8% (Industry Average ROE: 10.65%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 6.45
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.04
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 42 (Industry average Stock P/E: 115.9)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.61
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 14.41%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Hospitals & Medical Services | No.258/A, Bommasandra Industrial Area, Bengaluru Karnataka 560099 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Dr. Devi Prasad Shetty | Chairman & Wholetime Director |
| Mr. Viren Prasad Shetty | Executive Vice Chairman |
| Dr. Emmanuel Rupert | Managing Director & Group CEO |
| Dr. Kiran Mazumdar Shaw | Non Executive Director |
| Dr. Anesh Shetty | Non Executive Director |
| Ms. Nivruti Rai | Independent Director |
| Ms. Terri Smith Bresenham | Independent Director |
| Mr. Shankar Arunachalam | Independent Director |
| Dr. Nachiket Mor | Independent Director |
| Mr. Naveen Tewari | Independent Director |
FAQ
What is the intrinsic value of Narayana Hrudayalaya Ltd?
Narayana Hrudayalaya Ltd's intrinsic value (as of 25 January 2026) is ₹1944.16 which is 11.29% higher the current market price of ₹1,747.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹35,696 Cr. market cap, FY2025-2026 high/low of ₹2,372/1,259, reserves of ₹3,855 Cr, and liabilities of ₹7,742 Cr.
What is the Market Cap of Narayana Hrudayalaya Ltd?
The Market Cap of Narayana Hrudayalaya Ltd is 35,696 Cr..
What is the current Stock Price of Narayana Hrudayalaya Ltd as on 25 January 2026?
The current stock price of Narayana Hrudayalaya Ltd as on 25 January 2026 is ₹1,747.
What is the High / Low of Narayana Hrudayalaya Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Narayana Hrudayalaya Ltd stocks is ₹2,372/1,259.
What is the Stock P/E of Narayana Hrudayalaya Ltd?
The Stock P/E of Narayana Hrudayalaya Ltd is 42.0.
What is the Book Value of Narayana Hrudayalaya Ltd?
The Book Value of Narayana Hrudayalaya Ltd is 199.
What is the Dividend Yield of Narayana Hrudayalaya Ltd?
The Dividend Yield of Narayana Hrudayalaya Ltd is 0.26 %.
What is the ROCE of Narayana Hrudayalaya Ltd?
The ROCE of Narayana Hrudayalaya Ltd is 20.8 %.
What is the ROE of Narayana Hrudayalaya Ltd?
The ROE of Narayana Hrudayalaya Ltd is 24.2 %.
What is the Face Value of Narayana Hrudayalaya Ltd?
The Face Value of Narayana Hrudayalaya Ltd is 10.0.